Wong Vincent, Johnson Cheryl, Cowan Elliot, Rosenthal Matthew, Peeling Rosanna, Miralles Maria, Sands Anita, Brown Charlene
Office of HIV/AIDS, USAID, Washington, DC, 20004, USA,
AIDS Behav. 2014 Jul;18 Suppl 4:S415-21. doi: 10.1007/s10461-014-0825-9.
HIV self-testing (HIVST) is an emerging HIV testing strategy intended to address challenges of increasing access to preliminary knowledge of serostatus. It offers the potential for tests and testing to reach more people than previously possible, including those who do not seek testing in facilities. With approval of an HIV self-test kit in the USA, increasing evidence from public pilot programs in sub-Saharan Africa showing high acceptability and feasibility, and evidence of the informal sale of rapid HIV test kits in the private sector, options for individuals to access HIV self-testing, as well as consumer-demand, appear to be increasing. More recently WHO and UNAIDS have explored self-testing as an option to achieving greater HIV testing coverage to support global treatment targets. However, for resource-limited settings, technological development, diagnostic device regulation and quality assurance policies are lagging behind. This commentary will examine regulatory and policy issues with HIVST, given its increased prominence as a potential part of the global HIV/AIDS response.
艾滋病毒自我检测(HIVST)是一种新兴的艾滋病毒检测策略,旨在应对在增加获得血清学状态初步知识方面所面临的挑战。它使检测能够覆盖比以往更多的人,包括那些不在医疗机构进行检测的人。随着美国批准一种艾滋病毒自我检测试剂盒,撒哈拉以南非洲地区公共试点项目越来越多的证据表明其具有高度可接受性和可行性,以及私营部门存在快速艾滋病毒检测试剂盒的非正式销售情况,个人获得艾滋病毒自我检测的途径以及消费者需求似乎都在增加。最近,世界卫生组织和联合国艾滋病规划署探讨了将自我检测作为实现更高艾滋病毒检测覆盖率以支持全球治疗目标的一种选择。然而,在资源有限的环境中,技术发展、诊断设备监管和质量保证政策都滞后了。鉴于艾滋病毒自我检测作为全球艾滋病毒/艾滋病应对措施潜在组成部分的地位日益突出,本评论将审视与之相关的监管和政策问题。